Fabio Caputo Selected Research

4-hydroxybutyric acid

3/2016	A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.
5/2009	The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data.
1/2009	Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.
8/2007	Use of alcohol during the treatment of alcohol dependence with gamma-hydroxybutyric acid: risk of severe events are avoided by the dose fractioning of the drug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Caputo Research Topics

Disease

26	Alcoholism (Alcohol Abuse) 01/2022 - 09/2005
5	Liver Diseases (Liver Disease) 01/2022 - 11/2011
3	Infections 01/2022 - 01/2021
3	Hepatitis 10/2021 - 01/2020
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2020 - 11/2011
2	COVID-19 01/2022 - 01/2022
2	Hepatic Encephalopathy 01/2020 - 01/2019
2	Borderline Personality Disorder (Personality Disorders, Borderline) 03/2016 - 01/2014
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 02/2014 - 09/2003
2	Alcohol Withdrawal Delirium (Delirium Tremens) 03/2005 - 09/2003
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2022
1	Hemorrhage 06/2022
1	Alcohol-Related Disorders 10/2021
1	Acute-On-Chronic Liver Failure 10/2021
1	Myocarditis (Carditis) 01/2021
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2021
1	Alcoholic Hepatitis 06/2020
1	Exocrine Pancreatic Insufficiency 10/2019
1	Chronic Pancreatitis 10/2019
1	End Stage Liver Disease 01/2019
1	Mental Disorders (Mental Disorder) 03/2016
1	Hallucinations (Hallucination) 03/2015
1	Crohn Disease (Crohn's Disease) 12/2011
1	Acrodermatitis (Gianotti Crosti Syndrome) 12/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2007
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 03/2006
1	Tremor (Tremors) 03/2006
1	Substance-Related Disorders (Drug Abuse) 09/2002

Drug/Important Bio-Agent (IBA)

11	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 11/2021 - 09/2005
10	Pharmaceutical PreparationsIBA 01/2018 - 09/2002
9	Baclofen FDA LinkGeneric 10/2019 - 09/2003
4	gamma-Aminobutyric Acid (GABA)IBA 01/2019 - 01/2010
4	4-hydroxybutyric acidIBA 03/2016 - 08/2007
2	nalmefene (Revex)FDA Link 10/2019 - 04/2016
1	Capsules (Microcapsules)IBA 06/2022
1	SteroidsIBA 10/2021
1	Cocaine (Cocaine HCl)IBA 01/2021
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021
1	Heroin (Diamorphine)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Naltrexone (ReVia)FDA LinkGeneric 10/2019
1	Acamprosate (Campral)FDA Link 10/2019
1	Disulfiram (Antabuse)FDA Link 10/2019
1	Antipsychotic Agents (Antipsychotics)IBA 03/2015
1	Butyric Acid (Butanoic Acid)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 06/2012
1	metadoxineIBA 12/2011
1	Adalimumab (Humira)FDA Link 12/2011
1	GABA AgentsIBA 01/2010
1	CholesterolIBA 01/2007
1	Diazepam (Valium)FDA LinkGeneric 03/2006

Therapy/Procedure

8	Liver Transplantation 01/2022 - 11/2011
4	Therapeutics 09/2022 - 02/2014
1	Patient Readmission 01/2020
1	Contraindications 01/2020
1	Transplantation 01/2020
1	Injections 10/2019
1	Enzyme Replacement Therapy 10/2019
1	Secondary Prevention 02/2014
1	Drug Therapy (Chemotherapy) 12/2011